Real-time enrollment status for this low grade glioma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:38 AM UTC
| NCT Number | NCT06132685 |
| Recruiting Status | Recruiting |
| Condition | Low Grade Glioma |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | February 10, 2026 (Feb 10, 2026) |
As of July 18, 2026: Clinical trial NCT06132685 is currently recruiting participants. This phase2 study for low grade glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06132685 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06132685 was last updated Feb 10, 2026 (February 10, 2026). HelloStudys verifies this status automatically.